Market Closed -
Nyse
04:00:02 2024-06-18 pm EDT
|
5-day change
|
1st Jan Change
|
206.5
USD
|
+2.45%
|
|
+4.60%
|
-9.15%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
16,426
|
19,826
|
30,070
|
20,864
|
19,297
|
17,407
|
-
|
-
|
Enterprise Value (EV)
1 |
22,393
|
24,301
|
34,110
|
25,774
|
23,815
|
22,135
|
21,638
|
21,002
|
P/E ratio
|
20.3
x
|
12.8
x
|
12.9
x
|
16.9
x
|
47.6
x
|
18.2
x
|
15.8
x
|
14.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
1.43%
|
1.46%
|
1.47%
|
Capitalization / Revenue
|
1.42
x
|
1.42
x
|
1.87
x
|
1.4
x
|
1.59
x
|
1.36
x
|
1.3
x
|
1.24
x
|
EV / Revenue
|
1.94
x
|
1.74
x
|
2.12
x
|
1.73
x
|
1.96
x
|
1.73
x
|
1.61
x
|
1.5
x
|
EV / EBITDA
|
11
x
|
6.6
x
|
8.11
x
|
8.82
x
|
11.5
x
|
9.97
x
|
9.15
x
|
8.39
x
|
EV / FCF
|
21.4
x
|
13.9
x
|
12.9
x
|
17.5
x
|
27.2
x
|
20.7
x
|
17.5
x
|
14.5
x
|
FCF Yield
|
4.66%
|
7.22%
|
7.77%
|
5.72%
|
3.67%
|
4.84%
|
5.72%
|
6.88%
|
Price to Book
|
2.17
x
|
2.12
x
|
2.85
x
|
2.06
x
|
2.42
x
|
2.08
x
|
1.88
x
|
1.72
x
|
Nbr of stocks (in thousands)
|
97,100
|
97,400
|
95,700
|
88,600
|
84,900
|
84,294
|
-
|
-
|
Reference price
2 |
169.2
|
203.6
|
314.2
|
235.5
|
227.3
|
206.5
|
206.5
|
206.5
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,555
|
13,978
|
16,121
|
14,877
|
12,162
|
12,808
|
13,410
|
13,990
|
EBITDA
1 |
2,045
|
3,681
|
4,207
|
2,924
|
2,072
|
2,219
|
2,364
|
2,503
|
EBIT
1 |
1,711
|
3,332
|
3,831
|
2,549
|
1,715
|
1,839
|
1,967
|
2,119
|
Operating Margin
|
14.81%
|
23.84%
|
23.76%
|
17.13%
|
14.1%
|
14.36%
|
14.67%
|
15.15%
|
Earnings before Tax (EBT)
1 |
1,105
|
2,219
|
3,127
|
1,583
|
568.9
|
1,339
|
1,454
|
1,586
|
Net income
1 |
823.8
|
1,556
|
2,377
|
1,279
|
418
|
954.8
|
1,092
|
1,221
|
Net margin
|
7.13%
|
11.13%
|
14.75%
|
8.6%
|
3.44%
|
7.45%
|
8.14%
|
8.73%
|
EPS
2 |
8.350
|
15.88
|
24.39
|
13.97
|
4.770
|
11.34
|
13.04
|
14.57
|
Free Cash Flow
1 |
1,044
|
1,754
|
2,649
|
1,474
|
874.1
|
1,071
|
1,238
|
1,446
|
FCF margin
|
9.04%
|
12.54%
|
16.43%
|
9.91%
|
7.19%
|
8.36%
|
9.23%
|
10.33%
|
FCF Conversion (EBITDA)
|
51.08%
|
47.64%
|
62.98%
|
50.42%
|
42.18%
|
48.26%
|
52.36%
|
57.76%
|
FCF Conversion (Net income)
|
126.79%
|
112.69%
|
111.44%
|
115.24%
|
209.11%
|
112.17%
|
113.34%
|
118.4%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
2.948
|
3.005
|
3.028
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,056
|
3,900
|
3,697
|
3,606
|
3,674
|
3,778
|
3,034
|
3,057
|
3,033
|
3,177
|
3,189
|
3,230
|
3,229
|
3,362
|
3,363
|
EBITDA
1 |
997.3
|
888.4
|
748.8
|
681
|
605.5
|
590.1
|
539.6
|
514.1
|
482.1
|
547.2
|
567.6
|
568.2
|
552.1
|
593
|
597.5
|
EBIT
1 |
902.2
|
794
|
656.1
|
589.1
|
509.9
|
493.5
|
448.3
|
423.9
|
394.9
|
452.8
|
459.3
|
465.7
|
452.7
|
489.8
|
499.9
|
Operating Margin
|
22.24%
|
20.36%
|
17.75%
|
16.34%
|
13.88%
|
13.06%
|
14.78%
|
13.87%
|
13.02%
|
14.25%
|
14.4%
|
14.42%
|
14.02%
|
14.57%
|
14.87%
|
Earnings before Tax (EBT)
1 |
686
|
640.1
|
476.4
|
421.6
|
44.5
|
277.8
|
205
|
238.7
|
-147.1
|
297.4
|
361.3
|
350.1
|
320.5
|
378.5
|
353.7
|
Net income
1 |
553
|
491.6
|
358.6
|
352.8
|
76.1
|
212.9
|
188.9
|
183.3
|
-167.1
|
228
|
275.9
|
268.9
|
246.6
|
291.1
|
272.1
|
Net margin
|
13.63%
|
12.61%
|
9.7%
|
9.78%
|
2.07%
|
5.64%
|
6.23%
|
6%
|
-5.51%
|
7.18%
|
8.65%
|
8.32%
|
7.64%
|
8.66%
|
8.09%
|
EPS
2 |
5.750
|
5.230
|
3.870
|
3.900
|
0.8600
|
2.390
|
2.120
|
2.110
|
-1.970
|
2.690
|
3.038
|
2.928
|
2.753
|
3.245
|
3.160
|
Dividend per Share
2 |
-
|
-
|
0.7200
|
0.7200
|
-
|
0.7200
|
0.7200
|
-
|
-
|
0.7200
|
0.7413
|
0.7413
|
0.7413
|
0.7557
|
0.7557
|
Announcement Date
|
2/10/22
|
4/28/22
|
7/28/22
|
10/27/22
|
2/16/23
|
4/25/23
|
7/27/23
|
10/26/23
|
2/15/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,967
|
4,475
|
4,040
|
4,910
|
4,518
|
4,728
|
4,231
|
3,595
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.918
x
|
1.216
x
|
0.9605
x
|
1.679
x
|
2.18
x
|
2.131
x
|
1.79
x
|
1.436
x
|
Free Cash Flow
1 |
1,045
|
1,754
|
2,649
|
1,474
|
874
|
1,071
|
1,238
|
1,446
|
ROE (net income / shareholders' equity)
|
15.4%
|
27.7%
|
28.2%
|
17.9%
|
13.2%
|
15.5%
|
15.8%
|
15.8%
|
ROA (Net income/ Total Assets)
|
6.53%
|
12.3%
|
11%
|
4.5%
|
6.44%
|
6.65%
|
7.14%
|
7.68%
|
Assets
1 |
12,619
|
12,641
|
21,571
|
28,397
|
6,490
|
14,348
|
15,303
|
15,899
|
Book Value Per Share
2 |
77.80
|
96.00
|
110.0
|
114.0
|
93.90
|
99.40
|
110.0
|
120.0
|
Cash Flow per Share
2 |
14.70
|
21.80
|
31.90
|
21.40
|
15.20
|
17.70
|
20.00
|
22.90
|
Capex
1 |
400
|
382
|
460
|
482
|
454
|
468
|
475
|
502
|
Capex / Sales
|
3.46%
|
2.73%
|
2.86%
|
3.24%
|
3.73%
|
3.65%
|
3.54%
|
3.59%
|
Announcement Date
|
2/13/20
|
2/11/21
|
2/10/22
|
2/16/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
206.5
USD Average target price
237.6
USD Spread / Average Target +15.06% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.15% | 17.41B | | +25.85% | 89.22B | | -22.73% | 76.59B | | +3.24% | 26.87B | | +1.92% | 17.32B | | -0.42% | 15.25B | | +72.40% | 13.26B | | +81.96% | 13.43B | | -23.16% | 13.01B | | +25.01% | 12.75B |
Other Healthcare Facilities & Services
|